Peer-reviewedCC BYCurrent issues in molecular biology
Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling
- 1School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; (T.Y.);
- 2, Guiyang 550004, China
Related
- ZMIZ2–DUX4–LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple‐Negative Breast Cancer
- IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
- Targeting IRE1α/XBP1 signaling synergizes with cyclosporine A to ameliorate skin allograft rejection
- A native dairy-derived Streptococcus thermophilus potentiates docetaxel efficacy by modulating apoptotic and PI3K/AKT/mTOR signaling pathways in MCF-7 breast cancer cells
- Tangeretin ameliorates osteoarthritis and suppresses synovial macrophage M1 polarization in association with suppression of NF-κB signaling
BibTeX
@article{yang2026baicalein,
title = {{Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling}},
author = {Taomei Yang and Xiangyun Chen and Chunwei Chu and Yonghu Wan},
journal = {Current issues in molecular biology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703623},
note = {CC BY},
}
RIS
TY - JOUR
TI - Baicalein Synergizes with Docetaxel in TNBC and the Combination Suppresses AKT/GSK3β/β-Catenin Signaling
AU - Taomei Yang
AU - Xiangyun Chen
AU - Chunwei Chu
AU - Yonghu Wan
PY - 2026
DA - 2026/10/01
JO - Current issues in molecular biology
UR - https://europepmc.org/article/PMC/PMC13703623
SN - 1467-3037
SN - 1467-3045
ER -